Skip to content

Scott T. Garrett

Director at HCW Biologics.

Raised on HCW Biologics filings

$4M

of $4M offered across 1 Form D filing

Form D filings
1
Teammates
6
Last filing
Jun 8, 2026

Company

HCW Biologics

Biotech · Miramar, FL

Fusion protein drugs for inflammation-driven disease

Investors
7

HCW Biologics filings

  • EquityFiled Jun 8, 2026Form D
    $4M/ $4M

Works with